Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Evidence for host resistance in 1,3 bis(2-chloroethyl)-1-nitrosourea treatment induced in syngeneic LSA lymphoma

Summary

The anticancer agent 1,3 Bis(2-chloroethyl)-1-Nitrosourea (BCNU) cures the advanced syngeneic LSA lymphoma of C57BL mice with high efficiency. The cured animals resist further tumor challenge by large numbers of viable syngeneic tumor cells. Growth assays of spleen proliferation of the intravenously inoculated tumor revealed a progressive-regressive pattern of spleen growth after LSA-tumor injection. Lymphoma colony forming units (LCFU) in the spleen initially increased then regressed. In vitro assays of serum showed a alack of cytotoxic activity in mice cured by BCNU. Added spleen, thymus, or bone-marrow cells were similarly ineffective. Spleen and bone-marrow cells from immune mice passively transferred to normal mice showed weak cytotoxic activity against the LSA tumor. BCNU-cured mouse cells were more effective in protection than those cured with Chlorozotocin (CLZ).

This is a preview of subscription content, log in to check access.

References

  1. Axelrad A (1965) Antigenic behavior of lymphoma cell populations in mice as revealed by the spleen colony method. Prog Exp Tumor Res 6:30–83

  2. Bonmassar E, Bonmassar A, Vadlamudi, S, Goldin A (1970) Immunological alteration of leukemic cells in vivo after treatment with antitumor drugs. Proc Natl Acad Sci 66:1089–1095

  3. Bonmassar E, Testorelli C, Franco, P, Goldin A, Cudkowicz G (1975) Changes of the immunogenic properties of a radiation-induced mouse lymphoma following treatment with antitumor drugs. Cancer Res 35:1957–1962

  4. Feola JM, Maruyama Y (1979) Host resistance to tumor after cure of advanced lymphoma by treatment with BCNU and Chlorozotocin. Cancer Treat Rep 63:1409–1412

  5. Ferrer JF, Kaplan HS (1968) Antigenic characteristics of lymphomas induced by radiation leukemia virus (RadLV) in mice and rats. Cancer Res 28:2522–2528

  6. Glynn JP, Humphrey SR, Trivers G, Bianco AR, Goldin A (1968) Studies on immunity to leukemia l1210 in mice. Cancer Res 23:1008–1016

  7. Graff RJ, Valeriote F, Medoff G (1975) Marked histoincompatibility between and within sublines of AKR mice used in a syngeneic leukemic model. J Natl Cancer Inst 55:1015–1016

  8. Houchens DP, Bonmassar E, Gaston MR, Kende M, Goldin A (1976) Drug mediated immunogenic charges of virus induced leukemia in vivo. Cancer Res 36:1347–1352

  9. Ihle JN, McEwan R, Bengali K (1976) Radiation leukemia in C57BL/6 mice. I. Lack of serological evidence for the role of endogenous ecotropic viruses in pathogenesis. J Exp Med 144:1391–1405

  10. Johnson EA, Brown BW (1961) The Spearman estimator for serial dilution assay. Biometrics 17:79–88

  11. Kitano M, Mihich E, Pressman D (1972) Antigenic differences between leukemia L1210 and a subline resistant to methylglyoxal-bis(guanylhydrazone). Cancer Res 32:181–186

  12. Lieberman M, Kaplan HS (1959) Leukemogenic activity of filtrates from radiation-induced lymphoid tumors of mice. Science 130:387–389

  13. Maruyama Y (1967) Contribution of host resistance to radiosensitivity of an isologous mouse lymphoma cell by non-specific resistance. Int J Rad Biol 12:277–292

  14. Maruyama Y (1968) Lethal cell number for mouse lymphoma dosage-response studies: indirect study using intravenous inocula. Int J Cancer 3:788–794

  15. Maruyama Y (1969) Recognition of the irradiated, isogenic mouse lymphoma cell. Radiol 92:630–632

  16. Maruyama Y (1971) Host resistance and radiation response of syngeneic mouse lymphoma cells. J Natl Cancer Inst 46:963–971

  17. Maruyama Y (1976) Study of host immunological resistance to syngeneic lymphoma using whole body irradiation. Int J Radiat Oncol Biol Phys 1:1159–1169

  18. Maruyama Y, Ackerman E, Khan FM (1969) Inactivation of an X-irradiated tumor by independent processes in vivo. Int J Cancer 4:793–798

  19. Maruyama Y, Brown BW (1964) The growth of murine lymphomatous tumor cells as determined by host survival time. Int J Radiol Biol 8:59–73

  20. Maruyama Y, Feola JM (1973) Active host-resistance for transplant syngeneic C57BL lymphomas: Comparison of recently adapted and long transplanted tumors. Oncology 28:52–62

  21. Maruyama Y, Feola J (1969) 1,3 Bis(2-chloroethyl)-1-nitrosouera-induced host resistance to syngeneic mouse leukemias. Leukemia Res 4:417–415

  22. Maruyama Y, Johnson EA (1969) Quantiative study of isologous tumor cell inactivation and effective cell fraction for the LSA mouse lymphoma. Cancer 23:309–312

  23. Maruyama Y, Lee TC (1980) Growth, of LSA lymphoma in solid organs: demonstration of multiphasic growth. Cancer Biochem Biophys 4:257–263

  24. Medoff G, Valeriote F, Ryan J, Tolen S (1977) Response of transplanted AKR leukemia to combination therapy with amphotericin B and 1,3 bis(2-chloroethyl)-1-nitrosouera: Dose and schedude dependency. J Natl Cancer Inst 58:949–953

  25. Mihich E (1969) Combined effects of chemotherapy and immunity against leukemia L1210 in DBA/2 mice. Cancer Res 29:848–854

  26. Mihich E, Kitano M (1979) Differences in the immunogenicity of leukemia L1210 sublines in DBA/2 mice. Cancer Res 31:1999–2003

  27. Nicolin A, Bini A, Franco P, Goldin A (1979) Cell mediated response to a mouse leukemic subline antigenically altered following drug treatment in vivo. Cancer Chemother Rep 58:325–330

  28. Peters RL, Sass B, Stephenson JR, Al-Ghazzouli IK, Hino S, Donahue RM, Kende M, Aaronson SA, Kelloff GJ (1977) Immunoprevention of X-ray-induced leukemias in the C57BL mouse. Proc Natl Acad Sci 74:1697–1701

  29. Revesz L (1960) Detection of antigenic differences in isologous host-tumor systems by pretreatment with heavily irradiated tumor cells. Cancer Res 20:443–451

  30. Schabel FM Jr, Skipper HE, Laster WR Jr, Trader MW, Thompson SA (1966) Experimental evaluation of potential anticancer agents. XX. Development of immunity to leukemia L1210 in BDF1 mice and effects of therapy. Cancer Chemother Rep 50:55–77

  31. Silini G, Maruyama Y (1965) Studies of the LSA ascites lymphoma of C57BL mice. I. Transplantation characteristics and radiosensitivity of cells during serial passage. J Natl Cancer Inst 35:841–849

  32. Slettenmark B, Klein E (1962) Cytotoxic and neutralization tests with sera and lymph node cells of isologous mice with induced resistance to gross lymphomas. Cancer Res 22:947–961

Download references

Author information

Correspondence to Y. Maruyama.

Additional information

Supported by research grants nos. RO1 CA 13849, PO1 17786 from the National Cancer Institute, U.S. Public Health Service, U.S. Department of Health, Education and Welfare, Bethesda, Maryland 20014, The University of Kentucky Research Foundation, The Ephraim McDowell Cancer Network, and the Kircher Foundation

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Maruyama, Y., Williams, A., Feola, J.M. et al. Evidence for host resistance in 1,3 bis(2-chloroethyl)-1-nitrosourea treatment induced in syngeneic LSA lymphoma. J Cancer Res Clin Oncol 103, 107–118 (1982). https://doi.org/10.1007/BF00409641

Download citation

Key words

  • Host resistance
  • Chemotherapy
  • Tumor regression
  • Induced resistance